𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tryptophan hydroxylase autoantibodies and intestinal disease in autoimmune polyendocrine syndrome type 1

✍ Scribed by Olov Ekwall; Klas Sjöberg; Rita Mirakian; Fredrik Rorsman; Olle Kämpe

Book ID
117312610
Publisher
The Lancet
Year
1999
Tongue
English
Weight
27 KB
Volume
354
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autoimmune polyendocrine syndrome type 1
Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab
✍ Jonathan Popler; Mohammad Alimohammadi; Olle Kämpe; Frida Dalin; Megan K. Dishop 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB

## Abstract Autoimmune polyendocrine syndrome type 1 (APS‐1), also known as Autoimmune Polyendocrinopathy Candidiasis and Ectodermal Dysplasia (APECD) is a disorder caused by mutations in the autoimmune regulator (__AIRE__) gene. In some APS‐1 patients, significant pulmonary disease is observed. Au

Increased IL-17A secretion in response t
Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model
✍ Kerstin M. Ahlgren; Silvia Moretti; Brita Ardesjö Lundgren; Iulia Karlsson; Erik 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB

## Abstract Autoimmune polyendocrine syndrome type 1 (APS‐1) is a multiorgan autoimmune disease caused by mutations in the autoimmune regulator (AIRE) gene. Chronic mucocutaneous candidiasis, hypoparathyroidism and adrenal failure are hallmarks of the disease. The critical mechanisms causing chroni